Phase I and pharmacokinetic study of Yondelis™ (Ecteinascidin-743; ET-743) administered as an infusion over 1 h or 3 h every 21 days in patients with solid tumours

Reporting results of cancer treatment

A. B. Miller, Barth Hoogstraten, M. Staquet et al. · Cancer · 1981 · 7.9K citations

Pharmacy, Oncology, Clinical Data Management +16

The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux

Timothy W. Synold, Isabelle Dussault, Barry M. Forman · Nature Medicine · 2001 · 834 citations

Medicine, Molecular Biology, Pharmacology +11

DNA Sequence- and Structure-Selective Alkylation of Guanine N2 in the DNA Minor Groove by Ecteinascidin 743, a Potent Antitumor Compound from the Caribbean Tunicate <i>Ecteinascidia turbinata</i>

Yves Pommier, Glenda Kohlhagen, Christian Bailly et al. · Biochemistry · 1996 · 299 citations

Life Sciences, Biochemistry, Molecular Biology +16

Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action

Eugenio Erba, Daniele Bergamaschi, L Bassano et al. · European Journal of Cancer · 2001 · 257 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation

Shengkan Jin, Barbara Gorfajn, Glynn Faircloth et al. · Proceedings of the National Academy of Sciences · 2000 · 206 citations

Medicine, Molecular Biology, Pharmacology +15